4-88463979-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_016323.4(HERC5):āc.905G>Cā(p.Cys302Ser) variant causes a missense change. The variant allele was found at a frequency of 0.00336 in 1,612,714 control chromosomes in the GnomAD database, including 150 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0038 ( 15 hom., cov: 32)
Exomes š: 0.0033 ( 135 hom. )
Consequence
HERC5
NM_016323.4 missense
NM_016323.4 missense
Scores
8
7
3
Clinical Significance
Conservation
PhyloP100: 7.04
Genes affected
HERC5 (HGNC:24368): (HECT and RLD domain containing E3 ubiquitin protein ligase 5) This gene is a member of the HERC family of ubiquitin ligases and encodes a protein with a HECT domain and five RCC1 repeats. Pro-inflammatory cytokines upregulate expression of this gene in endothelial cells. The protein localizes to the cytoplasm and perinuclear region and functions as an interferon-induced E3 protein ligase that mediates ISGylation of protein targets. The protein also acts as a modulator of the antiviral immune response. The gene lies in a cluster of HERC family genes on chromosome 4. [provided by RefSeq, Aug 2021]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.015646249).
BP6
Variant 4-88463979-G-C is Benign according to our data. Variant chr4-88463979-G-C is described in ClinVar as [Benign]. Clinvar id is 789471.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0652 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
HERC5 | NM_016323.4 | c.905G>C | p.Cys302Ser | missense_variant | 6/23 | ENST00000264350.8 | |
HERC5 | XM_011532022.3 | c.905G>C | p.Cys302Ser | missense_variant | 6/21 | ||
LOC102723458 | XR_938972.3 | n.19+3652C>G | intron_variant, non_coding_transcript_variant | ||||
LOC102723458 | XR_938976.3 | n.76+3652C>G | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
HERC5 | ENST00000264350.8 | c.905G>C | p.Cys302Ser | missense_variant | 6/23 | 1 | NM_016323.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00379 AC: 576AN: 151880Hom.: 15 Cov.: 32
GnomAD3 genomes
AF:
AC:
576
AN:
151880
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00805 AC: 2019AN: 250814Hom.: 48 AF XY: 0.00690 AC XY: 935AN XY: 135576
GnomAD3 exomes
AF:
AC:
2019
AN:
250814
Hom.:
AF XY:
AC XY:
935
AN XY:
135576
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00332 AC: 4847AN: 1460716Hom.: 135 Cov.: 30 AF XY: 0.00317 AC XY: 2307AN XY: 726644
GnomAD4 exome
AF:
AC:
4847
AN:
1460716
Hom.:
Cov.:
30
AF XY:
AC XY:
2307
AN XY:
726644
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00377 AC: 573AN: 151998Hom.: 15 Cov.: 32 AF XY: 0.00414 AC XY: 308AN XY: 74308
GnomAD4 genome
AF:
AC:
573
AN:
151998
Hom.:
Cov.:
32
AF XY:
AC XY:
308
AN XY:
74308
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
2
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
5
ExAC
AF:
AC:
867
Asia WGS
AF:
AC:
93
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 02, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D
REVEL
Pathogenic
Sift
Pathogenic
D
Sift4G
Uncertain
D
Polyphen
D
Vest4
MutPred
Gain of MoRF binding (P = 0.0746);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at